Predictors for euthyroid sick syndrome and its impact on in-hospital clinical outcomes in high-risk patients undergoing coronary artery bypass grafting

Abstract

Objective:

The purpose of this cohort study was to investigate the independent relationship between euthyroid sick syndrome and in-hospital outcomes in high-risk patients undergoing isolated coronary artery bypass grafting, and we also examined the direct correlation between pre- or intra-operative variables and the incidence of coronary artery bypass grafting–associated euthyroid sick syndrome.

Methods:

The present study enrolled high-risk patients undergoing coronary artery bypass grafting from 1 January 2017 to 31 December 2017 in Beijing Anzhen hospital, including 387 (58.7%) patients with coronary artery bypass grafting–associated euthyroid sick syndrome and 272 (41.3%) patients without coronary artery bypass grafting–associated euthyroid sick syndrome.

Results:

The mean age of euthyroid sick syndrome group was significantly older than that of no euthyroid sick syndrome group (65.9 ± 7.5 vs 60.9 ± 9.6, p < 0.0001). Compared with the control group, significantly higher proportions of patients with euthyroid sick syndrome had presented with the following clinical characteristics at hospital admission: moderate and poor left ventricular ejection fraction (42.9% vs 28.7%, p < 0.0001), higher euroscore II (9.2 ± 4.1 vs 8.0 ± 3.9, p < 0.0001). Multivariate logistic regression analysis on the total patients revealed that the independent risk factors for coronary artery bypass grafting–associated euthyroid sick syndrome were advanced age (odds ratio = 1.07, 95% confidence interval = 1.05-1.09, p < 0.0001), higher euroscore II (odds ratio = 1.06, 95% confidence interval = 1.01-1.11, p = 0.013), and moderate and poor left ventricular ejection fraction (odds ratio = 2.26, 95% confidence interval = 1.61-3.18, p < 0.0001). Furthermore, euthyroid sick syndrome was independently correlated with an increased risk of in-hospital major adverse cardiovascular and cerebral events (odds ratio = 3.40, 95% confidence interval = 1.64-7.02, p = 0.001) and post-infection (odds ratio = 8.11, 95% confidence interval = 3.97-16.57, p < 0.0001) Besides, we also confirmed coronary artery bypass grafting–associated euthyroid sick syndrome was associated with Sequential Organ Failure Assessment maximum greater than 11 (odds ratio = 2.98, 95% confidence interval = 1.90-4.65, p < 0.0001), which predicted an in-hospital death rate of 95%, independently.

Conclusion:

Coronary artery bypass grafting–associated euthyroid sick syndrome exerted detrimental effects on short-term clinical outcomes in high-risk patients undergoing isolated coronary artery bypass grafting. Advanced age, higher euroscore II, and moderate and poor left ventricular ejection fraction were independent risk factors for coronary artery bypass grafting–associated euthyroid sick syndrome.

Keywords

coronary artery bypass grafting–associated euthyroid sick syndrome high-risk Sequential Organ Failure Assessment maximum major adverse cardiovascular and cerebral events

Get full access to this article

View all access options for this article.

References

Holland

2nd Brown

Jr Weintraub

, et al. Cardiopulmonary bypass and thyroid function: a “euthyroid sick syndrome.” Ann Thorac Surg 1991; 52: 46–50.

Cerillo

Sabatino

Bevilacqua

, et al. Nonthyroidal illness syndrome in off-pump coronary artery bypass grafting. Ann Thorac Surg 2003; 75: 82–87.

Bennett-Guerrero

Jimenez

White

, et al. Cardiovascular effects of intravenous triiodothyronine in patients undergoing coronary artery bypass graft surgery. A randomized, double-blind, placebo- controlled trial. Duke T3 study group. JAMA 1996; 275: 687–692.

Caluk

Osmanovic

Nonthyroidal illness syndrome in off-pump coronary artery bypass surgery. Anatol J Cardiol 2015; 15: 836–842.

Cerillo

Storti

Mariani

, et al. The non-thyroidal illness syndrome after coronary artery bypass grafting: a 6-month follow-up study. Clin Chem Lab Med 2005; 43: 289–293.

Gencer

Rodondi

Should we screen for hypothyroidism in patients with cardiovascular disease?

Eur Heart J 2016; 37: 2066–2068.

Spratt

Frohnauer

Cyr-Alves

, et al. Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am J Physiol Endocrinol Metab 2007; 293: E310–E315.

Utiger

RD.

Altered thyroid function in nonthyroidal illness and surgery. To treat or not to treat?

N Engl J Med 1995; 333: 1562–1563.

Iervasi

Pingitore

Landi

, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation 2003; 107: 708–713.

10.

Bettendorf

Schmidt

Grulich-Henn

, et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet 2000; 356: 529–534.

11.

Jonklaas

Bianco

Bauer

, et al. Guidelines for the treatment of hypothyroidism: prepared by the American thyroid association task force on thyroid hormone replacement. Thyroid 2014; 24: 1670–1751.

12.

Raza

Sabik

3rd Ainkaran

, et al. Coronary artery bypass grafting in diabetics: a growing health care cost crisis. J Thorac Cardiovasc Surg 2015; 150: 304.e2–312.e2.

13.

Pettila

Sequential assessment of multiple organ dysfunction as a predictor of outcome. JAMA 2002; 287: 713–714.

14.

Ferreira

Bota

Bross

, et al. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001; 286: 1754–1758.

15.

Velissaris

Tang

ATM

Wood

, et al. Thyroid function during coronary surgery with and without cardiopulmonary bypass. Eur J Cardiothorac Surg 2009; 36: 148–154.

16.

Wang

Liu

, et al. Non-thyroidal illness syndrome in patients with cardiovascular diseases: a systematic review and meta-analysis. Int J Cardiol 2017; 226: 1–10.

17.

Choi

Kwak

Kim

, et al. Peri-operative oral triiodothyronine replacement therapy to prevent postoperative low triiodothyronine state following valvular heart surgery. Anaesthesia 2009; 64: 871–877.

18.

Dulchavsky

Lucas

Ledgerwood

, et al. Triiodothyronine (T3) improves cardiovascular function during hemorrhagic shock. Circ Shock 1993; 39: 68–73.

19.

Laffey

Boylan

Cheng

DC.

The systemic inflammatory response to cardiac surgery: implications for the anesthesiologist. Anesthesiology 2002; 97: 215–252.

20.

Bello

Pennisi

Montini

, et al. Nonthyroidal illness syndrome and prolonged mechanical ventilation in patients admitted to the ICU. Chest 2009; 135: 1448–1454.

21.

Plikat

Langgartner

Buettner

, et al. Frequency and outcome of patients with nonthyroidal illness syndrome in a medical intensive care unit. Metabolism 2007; 56: 239–244.

22.

Loh

Eng

PC.

Prevalence and prognostic relevance of sick euthyroid syndrome in a medical intensive care unit. Ann Acad Med Singapore 1995; 24: 802–806.

23.

Antonelli

Moreno

Vincent

, et al. Application of SOFA score to trauma patients: Sequential Organ Failure Assessment. Intensive Care Med 1999; 25: 389–394.

24.

Fliers

Bianco

Langouche

, et al. Thyroid function in critically ill patients. Lancet Diabet Endocrinol 2015; 3: 816–825.

25.

Fekete

Lechan

Negative feedback regulation of hypophysiotropic thyrotropin-releasing hormone (TRH) synthesizing neurons: role of neuronal afferents and type 2 deiodinase. Front Neuroendocrinol 2007; 28: 97–114.

26.

Boelen

Kwakkel

Fliers

Beyond low plasma T3: local thyroid hormone metabolism during inflammation and infection. Endocr Rev 2011; 32: 670–693.

27.

Chopra

Sakane

Teco

GN.

A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. J Clin Endocrinol Metab 1991; 72: 1113–1116.

28.

Schutz

Bally

Stanga

, et al. Loss of appetite in acutely ill medical inpatients: physiological response or therapeutic target? Swiss Med Wkly 2014; 144: w13957.

29.

Chourdakis

Kraus

Tzellos

, et al. Effect of early compared with delayed enteral nutrition on endocrine function in patients with traumatic brain injury: an open-labeled randomized trial. J Parenter Enteral Nutr 2012; 36: 108–116.